# A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

> **NCT00454389** · PHASE3 · UNKNOWN · sponsor: **NeoVista** · enrollment: 494 (actual)

## Conditions studied

- Macular Degeneration

## Interventions

- **DEVICE:** Epi-Rad90™ Ophthalmic System
- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT00454389
- **Lead sponsor:** NeoVista
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** 2011-09
- **Final completion:** 2012-08
- **Target enrollment:** 494 (ACTUAL)
- **Last updated:** 2011-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454389, "A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00454389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*